Posner-Schlossman Syndrome (Glaucomatocyclitic Crisis): Diagnosis, CMV, Treatment and Long-Term Glaucoma Risk

Posner-Schlossman Syndrome (Glaucomatocyclitic Crisis): Diagnosis, CMV, Treatment and Long-Term Glaucoma Risk

Last updated: November 2026

Key points in 60 seconds

  • Recurrent, one-sided attacks of very high IOP (often 40 to 60 mmHg) with mild anterior uveitis and an open angle.
  • Symptoms are surprisingly mild for the pressure: blur, haloes, mild discomfort. Few, fine KPs; little flare; no synechiae.
  • Many cases, especially in Asian patients, are linked to cytomegalovirus (CMV); consider aqueous PCR in recurrent or atypical cases.
  • Treat attacks with a short course of topical steroid and aqueous suppressants; avoid pilocarpine.
  • It is not benign: repeated attacks cause glaucomatous damage in a substantial proportion over the years, so follow discs and fields between attacks.

A 35-year-old man comes with mild blur and coloured haloes in the right eye. IOP is 52 mmHg, the cornea is slightly hazy, there are three or four fine white KPs, a few cells, a deep open angle, and the other eye is normal. He has had "two similar episodes" before. This is the classic picture of Posner-Schlossman syndrome (PSS), also called glaucomatocyclitic crisis.

Clinical features

FeatureTypical in PSS
Age and sexUsually 20 to 50 years; more common in men
LateralityUnilateral, recurrent in the same eye (rarely the other eye)
IOPMarkedly raised, often 40 to 60 mmHg or more
SymptomsMild: blur, haloes, mild discomfort. Out of proportion to the pressure
CorneaEpithelial oedema from the high IOP
KPsFew, small, white, often central or inferior; may appear a day or two after the pressure rises
Anterior chamberFew cells and little flare
AngleOpen on gonioscopy; no peripheral anterior synechiae
Pupil and irisNo posterior synechiae; mild heterochromia or iris atrophy in some long-standing or CMV-positive cases
Between attacksIOP and outflow facility often return to normal

The CMV connection

Polymerase chain reaction (PCR) of aqueous humour has shown cytomegalovirus DNA in a large proportion of eyes with PSS, particularly in East and South-East Asian series. Herpes simplex and varicella zoster are found less often. CMV-positive eyes tend to have more attacks, more endothelial cell loss and a higher risk of glaucoma. Consider an aqueous tap for PCR when attacks are frequent, when steroids are needed for long periods, when there are coin-shaped KPs or endotheliitis, or before glaucoma surgery.

Differential diagnosis

ConditionDistinguishing features
Acute angle closureSevere pain, nausea, shallow chamber, mid-dilated pupil; angle closed on gonioscopy. Always do gonioscopy
Herpetic (HSV or VZV) anterior uveitisSectoral iris atrophy, reduced corneal sensation, past keratitis or skin rash, larger pigmented KPs
CMV anterior uveitis or endotheliitisChronic or recurrent, coin-shaped or linear KPs, endothelial cell loss; overlaps with PSS
Fuchs uveitis syndromeChronic, diffuse stellate KPs, heterochromia, cataract, vitreous cells; IOP rises gradually rather than in crises
Steroid responseIOP rises on steroid treatment rather than during inflammation
Pigment dispersion with pressure spikeSpike after exercise, Krukenberg spindle, heavy trabecular pigment
Uveitic glaucoma from other causesMore inflammation, synechiae, systemic associations

Treating an attack

Typical management of an acute attack

  1. Topical steroid, for example prednisolone acetate 1% four times a day, tapered quickly over one to three weeks as the inflammation settles. Loteprednol is an option when steroid response is a concern.
  2. Aqueous suppressants: beta-blocker (timolol), alpha-agonist (brimonidine) and topical carbonic anhydrase inhibitor (dorzolamide or brinzolamide), often as fixed combinations.
  3. Oral acetazolamide for very high IOP, if there is no contraindication.
  4. Avoid pilocarpine, which increases inflammation and is not needed in an open angle.
  5. Prostaglandin analogues are often avoided during active inflammation, although they are used by some clinicians.
  6. Review in a few days, then stop treatment once the eye is quiet and the IOP is normal. Watch for a steroid response.

Recurrent attacks and antivirals

  • For CMV-positive or frequently recurring PSS, topical ganciclovir (0.15% gel, or compounded 2% drops) is used, sometimes with oral valganciclovir for a limited period. Recurrence after stopping is common.
  • Give the patient a written plan to start treatment early at the first sign of an attack, and check the IOP within a day or two.
  • Do not leave patients on long-term steroids "to prevent attacks".

Long-term glaucoma risk and surgery

PSS used to be called self-limiting, but follow-up studies show that repeated attacks lead to glaucomatous optic neuropathy and field loss in a substantial proportion of patients, with risk increasing with the number of attacks and duration of disease (one Singapore series found about a three-fold higher risk of damage after ten years). Follow the disc, OCT and visual field between attacks, and set a target IOP if damage appears.

When the IOP cannot be controlled, trabeculectomy with mitomycin C or a glaucoma drainage device is used. Surgery controls the pressure but does not always stop the inflammatory attacks. Treat confirmed CMV before and after surgery.

Pearls

  • Very high IOP in a white, comfortable-looking eye with a few fine KPs: think PSS.
  • Gonioscopy is mandatory: the angle is open in PSS and closed in angle closure.
  • KPs may be absent on the first day; look again at review.
  • Recurrent or steroid-dependent PSS: consider aqueous PCR for CMV.
  • Examine the disc and fields between attacks; PSS is not harmless in the long run.

Common mistakes

  • Treating as acute angle closure with pilocarpine and laser iridotomy.
  • Continuing steroids for months and causing a steroid response.
  • Discharging the patient as "self-limiting" with no disc or field follow-up.
  • Missing CMV endotheliitis because only the IOP was treated.

Test yourself: flip cards

Quick quiz

Related: Uveitis Made Easy: SUN Terms, Patterns and Work-up, Uveitis Work-up: A Targeted Approach for Residents, How to Set a Target IOP in Glaucoma, Gonioscopy Grading: Shaffer, Scheie and Spaeth Systems, Glaucoma Medications Chart: Classes, IOP Lowering, Side Effects.

Key sources

  • Posner A, Schlossman A. Syndrome of unilateral recurrent attacks of glaucoma with cyclitic symptoms. Arch Ophthalmol. 1948;39:517-535
  • Jap A, Sivakumar M, Chee SP. Is Posner Schlossman syndrome benign? Ophthalmology. 2001;108:913-918
  • Chee SP, Jap A. Presumed Fuchs heterochromic iridocyclitis and Posner-Schlossman syndrome: comparison of cytomegalovirus-positive and negative eyes. Am J Ophthalmol. 2008;146:883-889
  • Megaw R, Agarwal PK. Posner-Schlossman syndrome. Surv Ophthalmol. 2017;62:277-285
  • Su CC, Hu FR, Wang TH, et al. Clinical outcomes in cytomegalovirus-positive Posner-Schlossman syndrome patients treated with topical ganciclovir therapy. Am J Ophthalmol. 2014;158:1024-1031

📘 Want more exam-ready material? See Most Commons in Ophthalmology on Kindle, or browse all my books.

How to cite this page

Patel D. Posner-Schlossman Syndrome (Glaucomatocyclitic Crisis): Diagnosis, CMV, Treatment and Long-Term Glaucoma Risk. RPC Rounds (Sadbhaav Eye Clinic). Updated November 2026. Available at: https://www.sadbhaavclinic.com/posner-schlossman-syndrome.html. Accessed [date].

Written and medically reviewed by Dr. Dhaval Patel, MD (Ophthalmology, AIIMS New Delhi) · Editorial policy

Consultant, Cataract & Refractive Surgery — among a small number of AIIMS-trained ophthalmologists practicing in Gujarat. Read full credentials & experience or view his 28 publications on ResearchGate.

📚 Also the author of OKAT Decoded, FRCOphth Decoded and other high-yield ophthalmology exam-prep books used by residents and PG aspirants.

Looking for an eye specialist in Ahmedabad? Glaucoma treatment at Sadbhaav or book a consultation with Dr. Dhaval Patel.